mDAP Culture Medium and Coating Matrix for Expansion and Maturation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing protocols for expanding and maturing midbrain Dopaminergic Progenitor cells (mDAPs) are laborious, long, and result in heterogeneous populations with low numbers, making them unsuitable for clinical applications.

Innovation Solution

A culture medium and coating matrix combination are developed to promote the expansion and maturation of mDAPs, comprising specific components such as neural growth supplements, WNT signaling pathway activators, ROCK inhibitors, TGF-β inhibitors, and polylysine-based compounds, along with appropriate coating matrices to enhance cell adhesion and marker expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing protocols are used for expanding and maturing mDAPs, then cell expansion and maturation can be achieved, but the process is laborious, time-consuming, and results in heterogeneous populations with low numbers

Engineering Contradiction:
Improveexpansion and maturation efficiencyVSAvoidprocess duration
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention changes the chemical parameters of the culture medium by incorporating specific small molecules (ROCK inhibitor, TGF-β inhibitor, WNT pathway activator) at optimized concentrations. This parameter optimization enables rapid expansion and maturation of mDAPs while maintaining population homogeneity, directly resolving the contradiction between productivity and time loss

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a composite culture medium system combining multiple signaling pathway modulators (ROCK inhibitor, TGF-β inhibitor, WNT activator) working synergistically. This composite approach achieves high-efficiency expansion and maturation in a single optimized protocol, eliminating the need for multiple sequential steps and reducing overall process time

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If existing protocols are used for expanding and maturing mDAPs, then cell expansion can be achieved, but the population becomes heterogeneous with relatively low numbers of midbrain DA neurons

Engineering Contradiction:
Improvenumber of mDAPsVSAvoidpopulation homogeneity
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The invention applies local quality control by using specific coating matrices (laminin, poly-D-lysine, poly-D-ornithine) on the culture substrate surface to create a localized microenvironment that promotes uniform mDAP expansion and maturation. This localized optimization ensures homogeneous population composition while maximizing cell numbers

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention optimizes the concentration parameters of key growth factors and signaling modulators in the culture medium. By precisely controlling the levels of ROCK inhibitor, TGF-β inhibitor, and WNT pathway activator, the protocol maintains population homogeneity while achieving high expansion yields

Inventive Principle:
Principle #35Parameter changes

3Reliability

If existing protocols are used for differentiating pluripotent stem cells into mDAPs, then differentiation can be achieved, but the process is laborious and highly variable between batches

Engineering Contradiction:
Improvebatch-to-batch consistencyVSAvoidprotocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention establishes a standardized protocol with precisely defined parameter ranges for all culture conditions, including small molecule concentrations, coating matrix types and concentrations, and culture duration. This parameter standardization ensures reproducible results across batches while simplifying the protocol for routine implementation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses small molecule inhibitors and activators as intermediaries to control multiple signaling pathways simultaneously. These molecular mediators provide precise, reproducible control over differentiation processes, eliminating the variability associated with more complex biological factors while maintaining protocol simplicity

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12391919B2Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
Publication Date: 2025.08.19 NUWACELL BIOTECHNOLOGIES CO LTD
  • US12391919B2 patent drawing
  • US12391919B2 patent drawing
  • US12391919B2 patent drawing

AI summary

The present disclosure described herein provides, inter alia, an expansion method for expanding mDAPs and a culture medium and a coating matrix combination used in the expansion method, as well as a maturation method for maturing mDAPs and a culture medium used in the maturation method. The present disclosure also provides a substantially homogeneous population of mDAPs and a substantially homogeneous population of mDANs.